HOME >> MEDICINE >> NEWS
Studies examine menopausal hormone therapy and risk of breast cancer recurrence

The doses of estrogen and progestogen used in menopausal hormone therapy may be related to the risk of breast cancer recurrence, according to a new study in the April 6 issue of the Journal of the National Cancer Institute.

In 1997, two randomized trials, the Hormonal Replacement Therapy--Is It Safe? (HABITS) trial and the Stockholm trial, began in Sweden to test the effects of menopausal hormone therapy in women after they had been diagnosed with early-stage breast cancer. The HABITS trial, which ultimately included 434 breast cancer patients, was halted early in December 2003 because, at a median follow-up of only 2.1 years, the risk of breast cancer recurrence among women receiving hormone therapy was 3.3 times higher than the risk among women receiving no treatment.

Eva von Schoultz, M.D., Ph.D., and Lars E. Rutqvist, M.D., Ph.D., of the Karolinska Institute, in Stockholm, Sweden, and the Stockholm Breast Cancer Study Group now report the results of the Stockholm trial, in which 378 breast cancer patients were randomly assigned to receive either menopausal hormone therapy for 5 years or no treatment. The trial was similar to the HABITS trial but used a hormone therapy regimen that differed in composition and timing.

In the Stockholm trial, after a median of 4.1 years of follow-up, there was no association between hormone therapy use and the risk of breast cancer recurrence. The authors suggest that differences in the composition and timing of the hormone therapy used in the Stockholm trial could explain why the trial's results differed from those of the HABITS trial.

"Although it is tempting to speculate that treatment regimens with estrogen and a minimum of progestogen may be safe, the management of menopausal symptoms and quality of life for patients with breast cancer remains an important unsolved problem," the authors write. "Because doses of estrogen and progestogen and treatment regimens may be associated with the rec
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
5-Apr-2005


Page: 1 2

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies suggest investigational agent reduces disease activity in MS
4. Studies highlight advances in diagnosis, medical therapy
5. Studies highlight real world use, safety of drug-eluting stents
6. Studies led by Rhode Island Hospital confirm safety and efficacy
7. Studies identify food sources of disease and drug resistance
8. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
9. Studies highlight need to monitor heart function in breast cancer patients
10. Studies examine physician disclosure of medical errors
11. Studies indicate medication can be an effective therapy for smoking cessation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2018)... RATON, Fla. (PRWEB) , ... August 15, 2018 , ... ... shirt on Kickstarter. , Born out of a desire for confidence ... underarm sweat marks and body odor – even in the hottest, most humid of ...
(Date:8/14/2018)... , ... August 14, 2018 , ... ... groups, today announced new leadership roles for healthcare executives Simon Frisch and Chris ... President, Florida, respectively. They assume their roles at a time of tremendous growth ...
(Date:8/11/2018)... ... August 10, 2018 , ... Dr. Siavash Eftekhari, Oral and ... Paraguay for a week-long international outpost trip to deliver dental care in impoverished communities. ... support staff, Dr. Eftekhari volunteered his time to help deliver care to over 550 ...
(Date:8/9/2018)... ... August 09, 2018 , ... Thousands of US ... according to cross-referenced data from The American Society of Plastic Surgeons (ASPS), The ... monitored by the FDA. As an MRI is recommended by FDA after the ...
(Date:8/9/2018)... ... 09, 2018 , ... Thanks to the generosity of ... customers, and employees, the newly established Isagenix Legacy Foundation raised $2.3 ... 100 percent of the donations will fund grants to nonprofit organizations that further ...
Breaking Medicine News(10 mins):
(Date:8/15/2018)... ... August 15, 2018 , ... Help Your Diabetes (HYD) is ... reverse their disease and get off their medication, working in conjunction with their primary ... in healthcare and is the author of "Imagine Living Without Type 2 Diabetes. Dr. ...
(Date:8/14/2018)... ANGELES (PRWEB) , ... August 14, 2018 , ... ... spearheading a unique fundraising event: The Saving Sophie Experience - A Journey To ... Hotel’s Tropicana Bar. Partygoers will have a meet and greet with Sophie herself, ...
(Date:8/11/2018)... , ... August 10, 2018 , ... Dry eye solutions® ... of these products are excellent, and they do provide some relief from dry eye ... than a product created and marketed by a small company in tiny Grants Pass, ...
Breaking Medicine Technology:
Cached News: